SCHEMBL9552126

SCHEMBL9552126

C=CCCn1nc(C(=O)c2ccccc2)nc1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 2/20 0.37
AGTR2 P50052 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9552573 0.90 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9552273 0.89 AGTR1 (0.44) AGTR1
SCHEMBL9553130 0.88 AGTR1 (0.39) AGTR1
SCHEMBL9552767 0.87 AGTR1 (0.51) AGTR1
SCHEMBL9552561 0.87 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9553613 0.87 AGTR1 (0.40) AGTR1
SCHEMBL9552035 0.86 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL9552575 0.86 AGTR1 (0.39) AGTR1
SCHEMBL9529729 0.86 AGTR1 (0.38) AGTR1AGTR2
SCHEMBL9552953 0.86 AGTR1 (0.37) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5229406-A Treatment of glaucoma G. D. SEARLE & CO. (US) 1993-07-20 US disclosed
US-5140036-A Hypotensive agents; congestive heart failure; angiotensin antagonists G. D. SEARLE & CO. (US) 1992-08-18 US disclosed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed